Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
Copur MS, Gnewuch C, Schriner M, Tharnish M, Gonen M, McDonald M, Kezeor J, Ramaekers RC, Gauchan D, Clark D, Greenwalt L, Mickey M, Norvell M.
Copur MS, et al. Among authors: gauchan d.
J Oncol Pharm Pract. 2018 Mar;24(2):116-120. doi: 10.1177/1078155217692400. Epub 2017 Feb 13.
J Oncol Pharm Pract. 2018.
PMID: 29284380